100 related articles for article (PubMed ID: 7392168)
1. Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.
Patten GA; Billi JE; Rotman HH
JAMA; 1980 Aug; 244(7):687-8. PubMed ID: 7392168
[No Abstract] [Full Text] [Related]
2. Fatal pneumothorax in "BCNU lung".
Wilson KS; Brigden ML; Alexander S; Worth A
Med Pediatr Oncol; 1982; 10(2):195-9. PubMed ID: 7070355
[TBL] [Abstract][Full Text] [Related]
3. Failure of corticosteroids to prevent carmustine-induced pulmonary fibrosis in a woman with astrocytoma.
Klein RC; Paddison RM
Arch Neurol; 1981 Jun; 38(6):392-3. PubMed ID: 7236075
[No Abstract] [Full Text] [Related]
4. BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.
Mitsudo SM; Greenwald ES; Banerji B; Koss LG
Cancer; 1984 Aug; 54(4):751-5. PubMed ID: 6744207
[TBL] [Abstract][Full Text] [Related]
5. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
Hasleton PS; O'Driscoll BR; Lynch P; Webster A; Kalra SJ; Gattamaneini HR; Woodcock AA; Poulter LW
J Pathol; 1991 May; 164(1):31-6. PubMed ID: 2056387
[TBL] [Abstract][Full Text] [Related]
6. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 41-1980.
N Engl J Med; 1980 Oct; 303(16):927-33. PubMed ID: 7412824
[No Abstract] [Full Text] [Related]
7. [Fatal pulmonary fibrosis induced by cytotoxic therapy].
Somló P; Révész T
Orv Hetil; 1984 May; 125(19):1143-5. PubMed ID: 6718003
[No Abstract] [Full Text] [Related]
8. Pulmonary toxicity from carmustine (BCNU): a case report.
Weiss RB; Shah S; Shane SR
Med Pediatr Oncol; 1979; 6(3):255-9. PubMed ID: 470840
[TBL] [Abstract][Full Text] [Related]
9. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
Selker RG; Jacobs SA; Moore PB; Wald M; Fisher ER; Cohen M; Bellot P
Neurosurgery; 1980 Dec; 7(6):560-5. PubMed ID: 7207751
[TBL] [Abstract][Full Text] [Related]
10. 25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood.
Lohani S; O'Driscoll BR; Woodcock AA
Chest; 2004 Sep; 126(3):1007. PubMed ID: 15364795
[No Abstract] [Full Text] [Related]
11. Carmustine toxicity presenting as a lobar infiltrate.
Patterson DL; Wiemann MC; Lee TH; Byron WA
Chest; 1993 Jul; 104(1):315-7. PubMed ID: 8325102
[TBL] [Abstract][Full Text] [Related]
12. Irreversible pulmonary toxicity after single course of BCNU.
Lieberman A; Ruoff M; Estey E; Seidman I; Lieberman I; Wise A
Am J Med Sci; 1980; 279(1):53-6. PubMed ID: 7369249
[TBL] [Abstract][Full Text] [Related]
13. Carmustine and the lungs .
Schmitz N; Diehl V
Lancet; 1997 Jun; 349(9067):1712-3. PubMed ID: 9193378
[No Abstract] [Full Text] [Related]
14. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
O'Driscoll BR; Hasleton PS; Taylor PM; Poulter LW; Gattameneni HR; Woodcock AA
N Engl J Med; 1990 Aug; 323(6):378-82. PubMed ID: 2370889
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary toxicity in long-term administration of BCNU.
Holoye PY; Jenkins DE; Greenberg SD
Cancer Treat Rep; 1976 Nov; 60(11):1691-4. PubMed ID: 1021241
[No Abstract] [Full Text] [Related]
16. Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Ryan BR; Walters TR
Cancer; 1981 Aug; 48(4):909-11. PubMed ID: 7272934
[TBL] [Abstract][Full Text] [Related]
17. Disseminated intravascular coagulation--a complication of 1,3-bis(2-chlorethyl)-nitrosourea therapy.
Siddiqi TS; Buchheit WA
Surg Neurol; 1983 Feb; 19(2):154-5. PubMed ID: 6845142
[No Abstract] [Full Text] [Related]
18. Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Bailey CC; Marsden HB; Jones PH
Cancer; 1978 Jul; 42(1):74-6. PubMed ID: 667809
[TBL] [Abstract][Full Text] [Related]
19. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
Parish JM; Muhm JR; Leslie KO
Mayo Clin Proc; 2003 May; 78(5):630-4. PubMed ID: 12744552
[TBL] [Abstract][Full Text] [Related]
20. Late carmustine lung fibrosis. Age at treatment may influence severity and survival.
O'Driscoll BR; Kalra S; Gattamaneni HR; Woodcock AA
Chest; 1995 May; 107(5):1355-7. PubMed ID: 7750330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
